-
Public release of clinical information
We are updating how we disclose the clinical information used to assess the safety and effectiveness of drugs and medical devices. -
Registration Decision RD2023-01, Bacillus amyloliquefaciens strain F727 and...
The Proposed Registration Decision PRD2022-13, Bacillus amyloliquefaciens strain F727 and Stargus Biofungicide. -
COVID-19 viral vector-based vaccines
Two of the vaccines approved for use in Canada are viral vector-based vaccines: AstraZeneca and Janssen. These types of vaccines use a harmless virus (in this case, the... -
Novel Food Information - Herbicide Tolerant Soybean SYHT0H2
Health Canada has notified Syngenta Seeds Canada Inc. and Bayer CropScience Inc. that it has no objection to the sale of food derived from Herbicide Tolerant Soybean SYHT0H2.... -
Smart meters
Utility companies in several provinces have installed wireless smart meters in Canadian businesses and residences. Learn about the safety of smart meters. -
Call for Information on Sodium Reduction Initiatives in the Canadian...
Food from foodservice establishments is often high in sodium. Excess sodium intake can increase the risk of high blood pressure, stroke, and chronic diseases such as heart or... -
Guidelines for Canadian Drinking Water Quality: Guideline Technical...
The maximum acceptable concentration (MAC) for N-nitrosodimethylamine (NDMA) in drinking water is 0.000 04 mg/L (0.04 µg/L). -
Compliance Verification Project 2020-2021: Cosmetic Regulations (Advance...
The Consumer Product Safety Program (CPSP) administers and enforces the Food and Drugs Act (FDA) and its Cosmetic Regulations. The purpose of this Compliance Verification (CV)... -
Notice of danger to human health or safety and risk mitigation for...
Health Canada has assessed the hazards associated with the use of free-standing clothing storage units. These products may pose a tip-over hazard to children. -
Exceptional importation and sale of drugs in relation to COVID-19: Overview
the Minister of Health signed the Interim Order No. 2 Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in Relation to COVID-19. IO No. 2 extends and... -
Guidelines for Canadian Drinking Water Quality: Guideline Technical Document...
This guideline technical document reviews and assesses all identified health risks associated with PFOA in drinking water. It incorporates available studies and approaches and... -
Health Product InfoWatch: February 2024
The following is a list of health product advisories, type I drug recalls and summaries of completed safety reviews published in January 2024 by Health Canada. -
Canada-Manitoba Bilateral Agreement for Pan-Canadian Virtual Care Priorities...
Canada and Manitoba agree that immediate action and collaboration was and continues to be needed among governments to expand virtual care services to support improved access to... -
Infant care: Services and information
Find safety information on baby slings, strollers, bottles and pacifiers. Also learn about infant nutrition. -
COVID-19 vaccines: Proof of vaccination
The secure, standardized proof of vaccination announced on August 11 is being developed in partnership with provinces and territories to facilitate travel outside of Canada. -
Clinical trials outline of process Frequently Asked Questions
Clinical trials: Frequently Asked Questions on outline of process. -
Registration Decision RD2021-03, Imazapyr, Habitat Aqua
This decision is consistent with the Proposed Registration Decision PRD2020-17, Imazapyr and Habitat Aqua, which contains a detailed evaluation of the information submitted in... -
Generic submissions under review
How to access a list of generic drug submissions currently under review. -
Information for Law Enforcement - Medical Use of Cannabis
The Access to Cannabis for Medical Purposes Regulations (ACMPR) provide the legal means through which Canadians can obtain access to cannabis for medical purposes, except as... -
Health Canada's Fees Report - 2019-20
This report, which is tabled under section 20 of the Service Fees Act and section 4.2.8 of the Directive on Charging and Special Financial Authorities, contains information...